Unraveling heterogeneity of CD271 signaling to discover new subpopulations of cells within the tumor has been fundamental to many advances in cancer biology, including identification of tumor-initiating subsets and cells resisting immune-therapeutic regimens9,18–20. This evidence concerns the gene NGFR and cancer.